Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor

World Journal of Gastroenterology

Volumn 15, Issue 15, 2009, Pages 1910-1913

  Hou, Ying Yong ^a   Zhou, Yang ^a   Lu, Shao Hua ^a   Qi, Wei Dong ^a   Xu, Cheng ^a   Hou, Jun ^a   Tan, Yun Shan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Gastrointestinal stromal tumor; Imatinib mesylate; Neoadjuvant

Indexed keywords

CD34 ANTIGEN; IMATINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ABDOMINAL DISCOMFORT; ABDOMINAL RADIOGRAPHY; ADJUVANT THERAPY; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE INTUSSUSCEPTION; MALE; MELENA; NEEDLE BIOPSY; RECTAL MALIGNANT GASTROINTESTINAL STROMAL TUMOR; RECTUM BIOPSY; RECTUM CANCER; SINGLE DRUG DOSE; TREATMENT PLANNING; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; ANTINEOPLASTIC AGENTS; DISEASE-FREE SURVIVAL; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; NEOADJUVANT THERAPY; PIPERAZINES; PYRIMIDINES; RECTAL NEOPLASMS;

EID: 67651253137     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.1910     Document Type: Article

References (22)

1. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, Silberman S, Capdeville R, Dimitrijevic S, Druker B, Demetri GD. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344: 1052-1056
2. Hassan I, You YN, Dozois EJ, Shayyan R, Smyrk TC, Okuno SH, Donohue JH. Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies. Dis Colon Rectum 2006; 49: 609-615
3. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30: 1213-1220
4. Miettinen M, Furlong M, Sarlomo-Rikala M, Burke A, Sobin LH, Lasota J. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am J Surg Pathol 2001; 25: 1121-1133
5. Aparicio T, Boige V, Sabourin JC, Crenn P, Ducreux M, Le Cesne A, Bonvalot S. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours. Eur J Surg Oncol 2004; 30: 1098-1103
6. Debiec-Rychter M, Cools J, Dumez H, Sciot R, Stul M, Mentens N, Vranckx H, Wasag B, Prenen H, Roesel J, Hagemeijer A, Van Oosterom A, Marynen P. Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. Gastroenterology 2005; 128: 270-279
7. Antonescu CR, Besmer P, Guo T, Arkun K, Hom G, Koryotowski B, Leversha MA, Jeffrey PD, Desantis D, Singer S, Brennan MF, Maki RG, DeMatteo RP. Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res 2005; 11: 4182-4190
8. Wardelmann E, Thomas N, Merkelbach-Bruse S, Pauls K, Speidel N, Büttner R, Bihl H, Leutner CC, Heinicke T, Hohenberger P. Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations. Lancet Oncol 2005; 6: 249-251
9. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol 2006; 23: 70-83
10. Williams DB, Sahai AV, Aabakken L, Penman ID, van Velse A, Webb J, Wilson M, Hoffman BJ, Hawes RH. Endoscopic ultrasound guided fine needle aspiration biopsy: a large single centre experience. Gut 1999; 44: 720-726
11. Fritscher-Ravens A, Sriram PV, Schröder S, Topalidis T, Bohnacker S, Soehendra N. Stromal tumor as a pitfall in EUS-guided fine-needle aspiration cytology. Gastrointest Endosc 2000; 51: 746-749
12. Vander Noot MR 3rd, Eloubeidi MA, Chen VK, Eltoum I, Jhala D, Jhala N, Syed S, Chhieng DC. Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 2004; 102: 157-163
13. Logrono R, Bhanot P, Chaya C, Cao L, Waxman I, Bhutani MS. Imaging, morphologic, and immunohistochemical correlation in gastrointestinal stromal tumors. Cancer 2006; 108: 257-266
14. Haller F, Detken S, Schulten HJ, Happel N, Gunawan B, Kuhlgatz J, Füzesi L. Surgical management after neoadjuvant imatinib therapy in gastrointestinal stromal tumours (GISTs) with respect to imatinib resistance caused by secondary KIT mutations. Ann Surg Oncol 2007; 14: 526-532
15. Bümming P, Andersson J, Meis-Kindblom JM, Klingenstierna H, Engström K, Stierner U, Wängberg B, Jansson S, Ahlman H, Kindblom LG, Nilsson B. Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients. Br J Cancer 2003; 89: 460-464
16. Liu CL, Huang MJ, Lin SC, Chang KM, Tzen CY. Neoadjuvant STI571 therapy for high-risk gastrointestinal stromal tumour. ANZ J Surg 2004; 74: 289-290
17. Katz D, Segal A, Alberton Y, Jurim O, Reissman P, Catane R, Cherny NI. Neoadjuvant imatinib for unresectable gastrointestinal stromal tumor. Anticancer Drugs 2004; 15: 599-602
18. Loughrey MB, Mitchell C, Mann GB, Michael M, Waring PM. Gastrointestinal stromal tumour treated with neoadjuvant imatinib. J Clin Pathol 2005; 58: 779-781
19. Lo SS, Papachristou GI, Finkelstein SD, Conroy WP, Schraut WH, Ramanathan RK. Neoadjuvant imatinib in gastrointestinal stromal tumor of the rectum: report of a case. Dis Colon Rectum 2005; 48: 1316-1319
20. Shah JN, Sun W, Seethala RR, Livolsi VA, Fry RD, Ginsberg GG. Neoadjuvant therapy with imatinib mesylate for locally advanced GI stromal tumor. Gastrointest Endosc 2005; 61: 625-627
21. Salazar M, Barata A, André S, Venâncio J, Francisco I, Cravo M, Nobre-Leitão C. First report of a complete pathological response of a pelvic GIST treated with imatinib as neoadjuvant therapy. Gut 2006; 55: 585-586
22. Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BW. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol 2007; 14: 14-24